GlassScriptPhysician profile
William Sy Lee
NPI 1285626325
$5,681.66
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,780 · 2020: $1,252 · 2021: $450 · 2022: $199.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,011.09 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $549.13 | 2019-2020 | |
| Amgen INC. | $348.48 | 2019-2020 | |
| Daiichi Sankyo INC. | $346.22 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $335.57 | 2019-2022 | |
| Abbvie INC. | $300.12 | 2019-2022 | |
| Pfizer INC. | $292.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $275.97 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $217.41 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $214.34 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $213.48 | 2019-2020 | |
| Glaxosmithkline, LLC. | $196.41 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $187.01 | 2019-2020 | |
| Allergan, INC. | $162.99 | 2019-2020 | |
| Lilly USA, LLC | $153.76 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $143.98 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $116.28 | 2019-2020 | |
| Amarin Pharma, INC. | $79.08 | 2019-2020 | |
| Astellas Pharma US INC | $76.68 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $74.09 | 2019 | |
| Antares Pharma, INC. | $51.66 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $45.56 | 2019 | |
| Genentech USA, INC. | $41.55 | 2019 | |
| Ironwood Pharmaceuticals, INC | $34.92 | 2019 | |
| Bausch Health US, LLC | $33.67 | 2019 | |
| Intuitive Surgical, INC. | $28.51 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.95 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $25.95 | 2021 | |
| Hikma Pharmaceuticals USA | $25.09 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.81 | 2019 | |
| Philips North America LLC | $16.92 | 2019 | |
| Horizon Therapeutics Plc | $16.39 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.15 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.